Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$16.98 USD
+0.33 (1.98%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $17.00 +0.02 (0.12%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.98 USD
+0.33 (1.98%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $17.00 +0.02 (0.12%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth D Momentum F VGM
Zacks News
Rocket Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Rocket Pharmaceuticals has been struggling lately, but the selling pressure may be coming to an end soon.
Why Rocket (RCKT) Stock Might be a Great Pick
by Zacks Equity Research
Rocket (RCKT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Here's Why Rocket Pharmaceuticals (RCKT) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Rocket Pharmaceuticals (RCKT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why Rocket Pharmaceuticals (RCKT) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Rocket Pharmaceuticals (RCKT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Rocket Pharmaceuticals, Inc. (RCKT) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Rocket Pharmaceuticals, Inc. (RCKT).
Rocket Pharmaceuticals (RCKT) in Focus: Stock Moves 7.2% Higher
by Zacks Equity Research
Rocket Pharmaceuticals (RCKT) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.